Search Results - Aparna Padhye
- Showing 1 - 2 results of 2
-
1
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers by David H. Peng, B. Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica Konen, Joshua K. Ochieng, Caleb A. Class, Jared J. Fradette, Laura Gibson, Limo Chen, Jing Wang, Lauren A. Byers, Don L. Gibbons
Published 2021Artigo -
2
A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections by Sumana Ghosh, M. Sinha, R. Samanta, Suresh Sadhasivam, Anamika Bhattacharyya, Ashis Nandy, Swamini Saini, Nupur Tandon, Himanshi Singh, Swati Gupta, Anjali Chauhan, Keerthi Kumar Aavula, Sneha Susan Varghese, Pujie Shi, Sudip Kumar Ghosh, Mukesh Garg, Tanmoy Saha, Aparna Padhye, S. Ghosh, Hae Lin Jang, Shiladitya Sengupta
Published 2022Artigo
Search Tools:
Related Subjects
Biology
Medicine
Antibiotics
Bacteria
Biochemistry
Blockade
Bone Infection
Bone cement
Cancer
Cancer research
Cell biology
Cement
Colorectal cancer
Combination therapy
Dentistry
Downregulation and upregulation
Gene
Genetics
Immune checkpoint
Immune system
Immunology
Immunotherapy
Implant
Internal medicine
KRAS
Kinase
Lung cancer
MAPK/ERK pathway
MEK inhibitor
Materials science